Two Randomized Trials of Low-Dose Calcium Supplementation in Pregnancy
New England Journal of Medicine · 2024
DOI: 10.1056/nejmc2401630 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von David Wright und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Exeter, Exeter, United Kingdom. Hauptthemen laut MEDLINE: Calcium, Calcium, Dietary, Dietary Supplements, Pre-Eclampsia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
To the Editor: The noninferiority trials of high-dose and low-dose calcium supplementation that were reported by Dwarkanath et al. (Jan. 11 issue) 1 were premised on the assumption that high-dose calcium supplementation would reduce the risk of preeclampsia by more than half. This assumption was based on the mean effect from a Cochrane Database random-effects meta-analysis of 13 trials (involving 15,730 women), which was used to support a World Health Organization (WHO) recommendation. 2,3 However, the trials that were included in the meta-analysis showed a high degree of heterogeneity, and the three largest trials, which accounted for 88% of the participants, showed . . .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Exeter, Exeter, United Kingdom.
- King's College Hospital, London, United Kingdom kypros@fetalmedicine.com.
Zitieren
APA
Wright, D., Wright, A., & Nicolaides, K. H. (2024). Two Randomized Trials of Low-Dose Calcium Supplementation in Pregnancy. New England Journal of Medicine. https://doi.org/10.1056/nejmc2401630
Vancouver
Wright D, Wright A, Nicolaides KH. Two Randomized Trials of Low-Dose Calcium Supplementation in Pregnancy. New England Journal of Medicine. 2024. doi:10.1056/nejmc2401630
BibTeX
@article{Wright2024,
author = {Wright, David and Wright, Alan and Nicolaides, Kypros H},
title = {Two Randomized Trials of Low-Dose Calcium Supplementation in Pregnancy},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmc2401630}
}
EUVIMED